Showing results (151-160 of 163) with videos related to
Sort By:
Pageof 17
Sensors (Basel, Switzerland)|April 29, 2020
Multimodal Breast Phantoms for Microwave, Ultrasound, Mammography, Magnetic Resonance and Computed Tomography ImagingGiuseppe Ruvio, Raffaele Solimene, Antonio Cuccaro, et al.Lancet (London, England)|April 20, 1985
Growth retardation in sickle-cell disease treated by nutritional supportM B Heyman, E Vichinsky, R Katz, et al.The Journal of Pediatrics|November 1, 1983
Immunologic abnormalities in patients with hemophilia AP S Weintrub, M A Koerper, J E Addiego, et al.Cellular Immunology|November 1, 1987
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitroM R Shalaby, J F Krowka, T J Gregory, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complexA C Collier, R W Coombs, D Katzenstein, et al.Growth Factors (Chur, Switzerland)|January 1, 1990
Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-beta 1L S Beck, T L Chen, S E Hirabayashi, et al.Pediatrics|April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivorsK Nielsen, G McSherry, A Petru, et al.AIDS Research and Human Retroviruses|August 9, 2002
Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmissionAnastasia Polycarpou, Christos Ntais, Bette T Korber, et al.The American Journal of Medicine|March 30, 1984
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseasesH D Ochs, S H Fischer, R J Wedgwood, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 yearsH J Senn, R Amgwerd, W F Jungi, et al.Pageof 17